Home with TablO outcoMEs (HOME) Registry

Brief description of study

This study is collecting information about the Tablo Hemodialysis System. This device has been cleared by FDA for home use and is commercially available. The Tablo device will be used per the approved intended use and the instructions for use. If you are a patient with end stage renal disease (ESRD) that is being adequately treated by maintenance dialysis and have chosen to receive in-home care with Tablo at home as part of your standard medical care. The purpose of this study is to collect medical information and your experiences using an in-home hemodialysis system called the Tablo® Hemodialysis System.

Clinical Study Identifier: s20-01031
Principal Investigator: Naveed N. Masani.
Other Investigator: James Drakakis.

If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.